bupropion has been researched along with reserpine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 5 (31.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Buckett, WR; Frankland, AT; Gosden, J; Heal, DJ; Hutchins, LJ; Luscombe, GP; Prow, MR | 1 |
| Minaian, A; Zarrindast, MR | 1 |
| Colin, JN; Lacomblez, L; Martin, P; Massol, J; Puech, AJ | 1 |
| Cooper, BR; Howard, JL; Soroko, FE | 1 |
| Cooper, BR; Cox, RF; Ferris, RM; Norton, R; Shea, V; Wang, CM | 1 |
| Gomita, Y; Nakagawa, T; Ohyama, T; Okamura, H; Ukai, K | 1 |
| Morita, M; Umezu, T | 1 |
| Bredeloux, P; Costentin, J; Dubuc, I | 1 |
| Dhir, A; Kulkarni, SK | 1 |
| Umezu, T | 1 |
1 review(s) available for bupropion and reserpine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
15 other study(ies) available for bupropion and reserpine
| Article | Year |
|---|---|
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A comparison of the effects of sibutramine hydrochloride, bupropion and methamphetamine on dopaminergic function: evidence that dopamine is not a pharmacological target for sibutramine.
Topics: Animals; Antidepressive Agents; Blepharoptosis; Brain Chemistry; Bupropion; Chromatography, High Pressure Liquid; Conditioning, Operant; Corpus Striatum; Cyclobutanes; Dopamine; Generalization, Psychological; Male; Methamphetamine; Rats; Reserpine; Stereotyped Behavior; Substantia Nigra | 1992 |
Different effects of direct and indirect dopamine receptor agonists on immobility time in reserpine-treated mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Bromocriptine; Bupropion; Dopamine Agents; Dopamine Antagonists; Ergolines; Injections, Subcutaneous; Male; Mice; Motor Activity; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Reserpine; Sulpiride; Swimming | 1991 |
Antidepressant profile of bupropion and three metabolites in mice.
Topics: Animals; Antidepressive Agents; Apomorphine; Body Temperature; Bupropion; Depression; Male; Mice; Motor Activity; Pimozide; Prazosin; Propiophenones; Propranolol; Reserpine; Yohimbine | 1990 |
Animal models used in prediction of antidepressant effects in man.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Bupropion; Depressive Disorder; Drug Evaluation, Preclinical; Drug Synergism; Helplessness, Learned; Humans; Levodopa; Mice; Models, Biological; Motor Activity; Propiophenones; Rats; Reserpine; Tetrabenazine | 1983 |
Evidence that the acute behavioral and electrophysiological effects of bupropion (Wellbutrin) are mediated by a noradrenergic mechanism.
Topics: Animals; Behavior, Animal; Brain Chemistry; Bupropion; Dopamine; Electrophysiology; Female; In Vitro Techniques; Locus Coeruleus; Neurons; Norepinephrine; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Reserpine; Serotonin; Substantia Nigra; Ventral Tegmental Area | 1994 |
Effect of dopaminergic drugs on the reserpine-induced lowering of hippocampal theta wave frequency in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Atropine; Bupropion; Cyclobutanes; Desipramine; Dopamine Agents; Dopamine Agonists; Hippocampus; Male; Methamphetamine; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine; Reserpine; Theta Rhythm | 2000 |
Evidence for the involvement of dopamine in ambulation promoted by menthol in mice.
Topics: alpha-Methyltyrosine; Amphetamine; Animals; Bupropion; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Injections, Subcutaneous; Male; Menthol; Mice; Mice, Inbred ICR; Motor Activity; Reserpine; Stimulation, Chemical; Tyrosine 3-Monooxygenase | 2003 |
Comparisons between bupropion and dexamphetamine in a range of in vivo tests exploring dopaminergic transmission.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antidepressive Agents, Second-Generation; Bupropion; Corpus Striatum; Dextroamphetamine; Dopamine; Epilepsy, Generalized; Homovanillic Acid; Male; Mice; Motor Activity; Nucleus Accumbens; Piperazines; Rats; Rats, Sprague-Dawley; Reserpine; Synaptic Transmission | 2007 |
Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor.
Topics: Animals; Antidepressive Agents, Second-Generation; Arginine; Behavior, Animal; Body Temperature; Brain; Bupropion; Cyclic GMP; Depression; Dopamine; Dopamine Uptake Inhibitors; Homovanillic Acid; Male; Mice; Motor Activity; Nitric Oxide; Norepinephrine; Rats; Rats, Wistar; Reserpine; Signal Transduction; Swimming | 2007 |
Evidence for dopamine involvement in ambulation promoted by pulegone in mice.
Topics: Animals; Bupropion; Cyclohexane Monoterpenes; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Drug Interactions; Male; Mice; Mice, Inbred ICR; Monoterpenes; Reserpine; Walking | 2010 |